The Cigna Group (CI) - 5i Research

The Cigna Group (CI $286.17)
- $286.17 P/E (TTM): 15.61X Cap: $76.38B
- View CI Profile
- View Questions on CI

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $272.98)
- $272.98 P/E (TTM): 22.16X Cap: $146.96B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $112.10)
- $112.10 P/E (TTM): 22.07X Cap: $139.09B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $220.61)
- $220.61 P/E (TTM): 104.56X Cap: $389.72B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $133.55)
- $133.55 P/E (TTM): 16.73X Cap: $232.43B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $286.17)
- $286.17 P/E (TTM): 15.61X Cap: $76.38B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $179.71)
- $179.71 P/E (TTM): 19.01X Cap: $432.80B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $94.22)
- $94.22 P/E (TTM): 26.05X Cap: $120.85B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.29)
- $20.29 P/E (TTM): 26.4X Cap: $1.44B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

The Cigna Group (CI $286.17)
- $286.17 P/E (TTM): 15.61X Cap: $76.38B
- View CI Profile
- View Questions on CI
Teladoc Health Inc. (TDOC $8.16)
- $8.16 Cap: $1.44B
- View TDOC Profile
- View Questions on TDOC
WELL Health Technologies Corp. (WELL $5.08)
- $5.08 Cap: $1.28B
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
Elevance Health Inc. (ELV $318.61)
- $318.61 P/E (TTM): 13.44X Cap: $71.74B
- View ELV Profile
- View Questions on ELV

Q: Hi there, wouldn't it be worthwhile for some to takeover WELL now, by paying a real good premium to todays price and yet... still scoop up WELL on the cheap, based on its future potential and better execution with new management/board?

If so, who do you feel would want to take over WELL?

What would be a good takeover price based on Q1 results and 2025 forward guidance?

Thanks!

Read Answer Asked by Hussein on May 15, 2025

The Cigna Group (CI $286.17)
- $286.17 P/E (TTM): 15.61X Cap: $76.38B
- View CI Profile
- View Questions on CI
UnitedHealth Group Incorporated (DE) (UNH $344.08)
- $344.08 P/E (TTM): 14.97X Cap: $311.62B
- View UNH Profile
- View Questions on UNH

Q: Hi 5i Team,

May I please have your comments on this company given the negative news relating to it that occurred a few months ago. Would it be a hold, buy or sell now? If it is a "sell", please recommend a company or companies to take its place.

Cheers,
H

Read Answer Asked by Harry on February 21, 2025